KeyBank National Association
AUPH icon

KeyBank National Association’s Aurinia Pharmaceuticals AUPH Stock Holding History

KeyBank National Association’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,800
Closed -$156K – 1056
2022
Q3 		$156K Hold
20,800
– – ﹤0.01% 1001
2022
Q2 		$209K Sell
20,800
-5,285
-20% -$59.1K ﹤0.01% 994
2022
Q1 		$323K Sell
26,085
-141
-0.5% -$2.18K ﹤0.01% 888
2021
Q4 		$600K Buy
26,226
+10,026
+62% +$238K ﹤0.01% 751
2021
Q3 		$359K Hold
16,200
– – ﹤0.01% 893
2021
Q2 		$210K Hold
16,200
– – ﹤0.01% 1030
2021
Q1 		$210K Buy
+16,200
New +$235K ﹤0.01% 1017

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return